Roche Holding Ltd. (ADR) 

(Public, OTC:RHHBY)   Watch this stock   
Find more results for RHHBY)
Apr 14, 2010
Q1 2010 AG Sales Release Add to calendar
Mar 23, 2010
AG at Kepler Equities Conference Add to calendar
Mar 18, 2010
AG Investor Day - 9:00AM EDT - Add to calendar
Mar 17, 2010
AG Event for the Investment Community Add to calendar
Mar 1, 2010
AG Annual General Meeting Add to calendar
Feb 5, 2010
Full Year 2009 AG Earnings Conference Call - New York
Feb 3, 2010
Full Year 2009 AG Earnings Conference Call - Afternoon
Feb 3, 2010
Full Year 2009 AG Earnings Conference Call - Morning
Feb 3, 2010
Full Year 2009 AG Earnings Release
Jan 10, 2010
AG at JPMorgan Healthcare Conference
  

Key stats and ratios

Q4 (Dec '09) 2009
Net profit margin 17.80% 17.35%
Operating margin 26.57% 24.22%
EBITD margin - 29.71%
Return on average assets 11.76% 11.30%
Return on average equity 160.15% 30.03%
Employees 81,507 -

Address

Grenzacherstrasse 124
Basel, 4070
Switzerland
+41-61-6881111 (Phone)
+41-61-6919391 (Fax)

Website links

Roche Holding Ltd. (ADR) discussions

  View all discussions »

Description

Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. The Company belongs to the Roche Group that operates through numerous subsidiaries and associated companies located around the world. The Company discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. Roche operates through two divisions: Pharmaceuticals and Diagnostics. Within the Pharmaceuticals Division there are three sub-divisions: Roche Pharmaceuticals, Genentech and Chugai. The Company’s Diagnostics Division includes five sub-divisions: Roche Applied Science, Roche Diabetes Care, Roche Molecular Diagnostics, Roche Tissue Diagnosis and Roche Professional Diagnostics. Its activities are structured into six geographical segments: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan.

Officers and directors

Severin Schwan
Chairman of the Corporate Executive Committee, Chief Executive Officer
Age: 43
Erich Hunziker
Chief Financial Officer, Deputy Head of the Corporate Executive Committee
Age: 56
Gottlieb A. Keller
Member of the Corporate Executive Committee, General Counsel, Head of Corporate Services, Secretary
Age: 56
Rene Kissling
Secretary to the Corporate Executive Committee
Age: 44
Silvia Ayyoubi
Member of the Corporate Executive Committee, Head of Corporate Human Resources
Age: 57
Pascal Soriot
Member of the Corporate Executive Committee, COO Pharmaceuticals Division, CEO of Genentech
Age: 51
Daniel O'Day
Corporate Executive Committee, COO of Diagnostics Division
Age: 46
Franz B. Humer
Non-Executive Chairman of the Board of Directors
Age: 63
Fritz Gerber
Honorary Chairman of the Board
Age: 80
Andre Hoffmann
Non-Executive Vice Chairman of the Board
Age: 51